Estimations des analystes de Wall Street pour Crinetics Pharmaceuticals, Inc. (CRNX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 13 |
| Conserver | 8 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 21 |
| Note moyenne (1-5) | 0.62 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-1.20 | ||
| 2026-08-03 | $-1.14 | $-1.18 | +3.4% |
| 2026-05-07 | $-1.23 | $-1.22 | -0.8% |
| 2026-02-26 | $-1.29 | $-1.37 | +5.8% |
| 2025-11-06 | $-1.38 | $-1.27 | -8.7% |
| 2025-08-07 | $-1.23 | $-1.13 | -8.8% |
| 2025-05-08 | $-1.04 | $-0.99 | -5.1% |
| 2025-02-27 | $-0.88 | $-0.92 | +4.3% |
Ratios de valorisation
| Prix / Valeur comptable | 7.52 |
| EV / EBITDA | -17.68 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $589000 | $2.0M | $2.4M | $1.2M | $71000 | $1.1M | $4.7M | $4.0M | $1.0M | $7.7M |
| Coût des Ventes | $5.1M | $9.2M | $24.5M | $1.1M | $57.0M | 0 | 0 | 0 | 0 | $1.1M |
| Marge Brute | -$4.5M | -$7.2M | -$22.1M | $80000 | -$56.9M | $1.1M | $4.7M | $4.0M | $1.0M | $6.6M |
| R&D | $5.1M | $9.2M | $24.5M | $41.5M | $57.6M | $84.3M | $130.2M | $168.5M | $240.2M | $332.1M |
| Frais Généraux | $1.5M | $1.9M | $6.7M | $13.5M | $18.0M | $24.5M | $42.4M | $58.1M | $99.7M | $191.3M |
| Charges Opérationnelles | $6.0M | $9.1M | $28.7M | $53.8M | $18.0M | $108.8M | $172.6M | $226.6M | $339.9M | $523.4M |
| Résultat Opérationnel | -$6.0M | -$9.1M | -$28.7M | -$53.8M | -$75.0M | -$107.7M | -$167.9M | -$222.6M | -$338.9M | -$516.8M |
| EBITDA | -$6.0M | -$9.0M | -$28.2M | -$49.3M | -$74.0M | -$106.7M | -$162.9M | -$213.4M | -$295.6M | -$461.2M |
| Charges d'Intérêt | $11000 | $8000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$6.0M | -$9.2M | -$27.1M | -$50.4M | -$73.8M | -$107.6M | -$163.9M | -$214.5M | -$298.4M | -$465.1M |
| Impôts | $10000 | -$40000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $180000 |
| Résultat Net | -$6.0M | -$9.2M | -$27.1M | -$49.5M | -$73.8M | -$107.6M | -$163.9M | -$214.5M | -$298.4M | -$465.3M |
| BPA | $-0.43 | $-0.66 | $-2.23 | $-2.05 | $-2.42 | $-2.80 | $-3.15 | $-3.69 | $-3.69 | $-4.95 |
| BPA Dilué | $-0.43 | $-0.66 | $-2.23 | $-2.05 | $-2.42 | $-2.80 | $-3.15 | $-3.69 | $-3.69 | $-4.95 |
| Actions en Circulation (Diluées) | $13.9M | $13.9M | $12.1M | $24.2M | $30.4M | $38.4M | $52.0M | $58.1M | $80.8M | $94.1M |
Prix
| Prix | $84.95 |
| Capitalisation | $9.0B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ACAD · AKRO · DYN · IMVT · KYMR · NAMS · PRAX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CRNX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions